Wire · operational-macro
Kirkland Advises Trilantic-Backed SOFIE Biosciences on Acquisition by GE HealthCare
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 5 October 2026 · Fusion42 review
Trilantic-backed SOFIE Biosciences is being acquired by GE HealthCare for $945 million in cash, to close in the first half of 2027 pending regulatory approvals. This acquisition establishes GE HealthCare's presence in the critical final mile of U.S. PET radiopharmaceutical supply within its PDx segment.
This Wire brief sits within Fusion42's coverage of Health, and 4 sources have reported it between 5 Oct 2026 and 6 Oct 2026.
◆ ◆ The Wire takeaway
You face a new competitor with GE HealthCare fully owning the final delivery step in U.S. PET radiopharmaceuticals. This tightens market control and may squeeze smaller contract manufacturers or distributors.
◆ Coverage
4 sources · first reported 5 Oct 2026 · latest 6 Oct 2026
◆ Related on Wire
◆ Topics